Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

M. Somlyay; E. Durinikova; J. Besnard; O. Barbeau; J. Le Coz; M. Senekowitsch; B. Ergüner; K. Hackner; L. Dzurillova; E. Petru; J. Lafleur; J. Singer; T. Füreder; R. Paveley; J. Joseph; F. Aswad; T. Winkler-Penz; R. Sehlke; C. Boudesco; G. Vladimer

doi:10.1016/S0959-8049(22)00919-4

Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

M. Somlyay
, E. Durinikova
, J. Besnard
, O. Barbeau
, J. Le Coz
, M. Senekowitsch
, B. Ergüner
, K. Hackner
, L. Dzurillova
, E. Petru
, J. Lafleur
, J. Singer
, T. Füreder
, R. Paveley
, J. Joseph
, F. Aswad
, T. Winkler-Penz
, R. Sehlke
, C. Boudesco
, G. Vladimer

Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Konferenzbeitrag in Fachzeitschrift

Originalsprache	Englisch
Seiten (von - bis)	S44-S45
Fachzeitschrift	European Journal of Cancer
Jahrgang	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00919-4
Publikationsstatus	Veröffentlicht - Okt. 2022

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

ASJC Scopus Sachgebiete

Onkologie
Krebsforschung

Zugriff auf Dokument

10.1016/S0959-8049(22)00919-4

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Somlyay, M., Durinikova, E., Besnard, J., Barbeau, O., Le Coz, J., Senekowitsch, M., Ergüner, B., Hackner, K., Dzurillova, L., Petru, E., Lafleur, J., Singer, J., Füreder, T., Paveley, R., Joseph, J., Aswad, F., Winkler-Penz, T., Sehlke, R., Boudesco, C., & Vladimer, G. (2022). Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling. European Journal of Cancer, 174, S44-S45. https://doi.org/10.1016/S0959-8049(22)00919-4

@article{9896946615cc4da3a48f0e045b563cea,

title = "Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling",

author = "M. Somlyay and E. Durinikova and J. Besnard and O. Barbeau and \{Le Coz\}, J. and M. Senekowitsch and B. Erg{\"u}ner and K. Hackner and L. Dzurillova and E. Petru and J. Lafleur and J. Singer and T. F{\"u}reder and R. Paveley and J. Joseph and F. Aswad and T. Winkler-Penz and R. Sehlke and C. Boudesco and G. Vladimer",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00919-4",

language = "English",

volume = "174",

pages = "S44--S45",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Somlyay, M, Durinikova, E, Besnard, J, Barbeau, O, Le Coz, J, Senekowitsch, M, Ergüner, B, Hackner, K, Dzurillova, L, Petru, E, Lafleur, J, Singer, J, Füreder, T, Paveley, R, Joseph, J, Aswad, F, Winkler-Penz, T, Sehlke, R, Boudesco, C & Vladimer, G 2022, 'Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling', European Journal of Cancer, Jg. 174, S. S44-S45. https://doi.org/10.1016/S0959-8049(22)00919-4

TY - JOUR

T1 - Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

AU - Somlyay, M.

AU - Durinikova, E.

AU - Besnard, J.

AU - Barbeau, O.

AU - Le Coz, J.

AU - Senekowitsch, M.

AU - Ergüner, B.

AU - Hackner, K.

AU - Dzurillova, L.

AU - Petru, E.

AU - Lafleur, J.

AU - Singer, J.

AU - Füreder, T.

AU - Paveley, R.

AU - Joseph, J.

AU - Aswad, F.

AU - Winkler-Penz, T.

AU - Sehlke, R.

AU - Boudesco, C.

AU - Vladimer, G.

PY - 2022/10

Y1 - 2022/10

UR - https://www.scopus.com/pages/publications/85140465390

U2 - 10.1016/S0959-8049(22)00919-4

DO - 10.1016/S0959-8049(22)00919-4

M3 - Conference contribution to journal

AN - SCOPUS:85140465390

SN - 0959-8049

VL - 174

SP - S44-S45

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -